The Scientific and Research Team at Remix Therapeutics spearheads the discovery and development of innovative small molecule therapies by leveraging advanced RNA processing techniques. Comprised of experts in chemistry, bioinformatics, biomolecular sciences, and medicinal chemistry, the team collaborates to identify and optimize therapeutic candidates, conduct rigorous preclinical studies, and ensure proper chemical manufacturing and control (CMC) processes.
Benoît Moreau
Head, Medicinal Chemistry
Brandi Hudson
Principal Scientist
Cassandra Schaening-...
Scientist, Bioinformatics and ...
Dominic Reynolds
SVP, Chemistry
Fred Vaillancourt
VP, Biomolecular Sciences & Le...
Matthew Schnaderbeck
Sr. Director, CMC
Nirodhini Siriwardan...
Associate Director, Biomolecul...
Silvia Buonamici
SVP, in silico & in vivo Biosc...
View all